Avadel Pharmaceuticals PLC (NAS:AVDL)
$ 13.945 0.295 (2.16%) Market Cap: 1.34 Bil Enterprise Value: 1.24 Bil PE Ratio: 0 PB Ratio: 19.10 GF Score: 43/100

Avadel Pharmaceuticals PLC at H C Wainwright BioConnect Conference (Virtual) Transcript

Jan 11, 2021 / NTS GMT
Release Date Price: $6.82 (-0.29%)
Oren Gabriel Livnat
H.C. Wainwright & Co, LLC, Research Division - MD & Senior Healthcare Analyst

Welcome to the H.C. Wainwright 2021 BioConnect Conference. My name is Oren Livnat, the spec pharma analyst here at H.C. Wainwright. It's my pleasure to welcome our presenter, Avadel. And with us today is CEO, Greg Divis. Welcome, Greg.

Gregory J. Divis
Avadel Pharmaceuticals plc - CEO & Director

Thank you, Oren, a pleasure to be here, appreciate the opportunity.

Oren Gabriel Livnat
H.C. Wainwright & Co, LLC, Research Division - MD & Senior Healthcare Analyst

No problem.

Questions & Answers

Oren Gabriel Livnat
H.C. Wainwright & Co, LLC, Research Division - MD & Senior Healthcare Analyst

So we spoke a few months ago, and did one of these fireside chats. And since then, you guys have come through and filed the on-time the NDA for FT218, your once-nightly sodium oxybate for narcolepsy, which for those who don't know, is essentially a new and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot